Table 3.

Articles reporting regenerating islet-derived type IV as biomarker

Author	Year	Type of cancer	Result
Oue et al[18]	2007	Colorectal	Serum RegIV concentration was significantly elevated in patients with liver metastases than those without
Mitani et al[19]	2007	Gastric	Presurgical serum RegIV was significantly elevated compared with healthy individuals
Kobayashi et al[59]	2010	Gastric	Presurgical serum RegIV was significantly different in early and advanced cancer, compared with healthy individuals

RegIV: Reporting regenerating islet-derived type IV.